Is acetaminophen (paracetamol) use in children after cardiac surgery protective against Acute Kidney Injury (AKI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetaminophen Use in Children After Cardiac Surgery for AKI Protection

Acetaminophen administration in the early postoperative period is associated with reduced risk of acute kidney injury (AKI) in children undergoing cardiac surgery with cardiopulmonary bypass. 1

Evidence for Renal Protection

  • Early postoperative acetaminophen exposure shows a dose-dependent protective effect against AKI in pediatric cardiac surgery patients, with higher doses (up to 78 mg/kg in the first 48 hours) associated with lower AKI rates 1
  • This protective effect was demonstrated in a retrospective cohort study and validated in a second cohort, with adjusted odds ratios showing significant protection (OR 0.86 [95% CI, 0.82-0.90] per additional 10 mg/kg in the primary cohort) 1
  • The mechanism may involve acetaminophen's ability to reduce oxidative injury by decreasing the oxidation state of free hemoglobin released during cardiopulmonary bypass 1

Dosing Considerations

  • For children undergoing cardiac surgery, intravenous acetaminophen is preferred initially, with transition to oral administration as soon as possible 2, 3
  • Standard dosing recommendations:
    • For children <10 kg: 7.5 mg/kg IV every 8 hours 4
    • For children ≥10 kg: 15 mg/kg IV every 8 hours 4
  • Total daily dose should not exceed 90 mg/kg in otherwise healthy children to minimize risk of liver toxicity 5

Pharmacokinetic Considerations in Cardiac Surgery Patients

  • Children after cardiac surgery with cardiopulmonary bypass have altered acetaminophen pharmacokinetics compared to non-cardiac surgery patients 4:
    • Lower clearance
    • Higher volume of distribution
  • No significant pharmacokinetic differences have been observed between cyanotic and acyanotic congenital heart disease patients 6

Clinical Implementation

  • Acetaminophen should be incorporated as part of multimodal analgesia after cardiac surgery 3
  • Administration should begin early in the postoperative period and continue for at least 48 hours to maximize renal protection 1
  • Intravenous administration is preferred initially until gut function recovers, then transition to oral route 2, 3

Monitoring and Precautions

  • Standard monitoring of liver function is recommended, particularly in patients with pre-existing hepatic disease 3
  • While acetaminophen is generally safe at therapeutic doses, rare cases of AKI associated with therapeutic doses have been reported, particularly in children with volume depletion 7
  • Monitor for signs of dehydration or volume depletion, which may increase risk of adverse effects 7

Advantages Over Alternative Analgesics

  • Acetaminophen has fewer adverse effects on renal function compared to NSAIDs, which can worsen renal dysfunction after cardiac surgery 3
  • Provides opioid-sparing effects, reducing risks of respiratory depression, nausea, vomiting, and ileus 3

This evidence suggests that acetaminophen should be considered not only for its analgesic properties but also as a potential renoprotective agent in children undergoing cardiac surgery with cardiopulmonary bypass.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.